Skip to main content
# Title Research Member Research Year
71 4. Liposomal Doxorubicin based Chemotherapy in the treatment
of Relapsed Diffuse Large B-cell Lymphoma

Dr. Hanaan Ahmed Mohammed Ahmed 2020
72 Is survival with Conservative Breast Therapy becoming Superior to that with Modified Radical Mastectomy alone for the Treatment of Early Breast Cancer in this Era? Dr. Salah Mabrouk Khallaf Abd Rabou 2020
73 Pegylated liposomal doxorubicin in patients with metastatic triple-negative breast cancer: 8-year experience of a single center Yasmine Ali Roshdy 2020
74 Evaluation the Possibility of Using of miRNA-21 as a Prognostic and Predictive Factor in Colorectal Cancer (South Egypt Experience)
Dr. Mayada Fawzy Sedik Farghaly 2020
75 4. Liposomal Doxorubicin based Chemotherapy in the treatment
of Relapsed Diffuse Large B-cell Lymphoma

Dr. Amen Hamdy Zaki Ali 2020
76 Evaluation the Possibility of Using of miRNA-21 as a Prognostic and Predictive Factor in Colorectal Cancer (South Egypt Experience)
Sanaa Saber Abdelraheem Barakat 2020
77 4. Liposomal Doxorubicin based Chemotherapy in the treatment
of Relapsed Diffuse Large B-cell Lymphoma

Rabab Mohammed Mamdouh Abdelhameed 2020
78 Is survival with Conservative Breast Therapy becoming Superior to that with Modified Radical Mastectomy alone for the Treatment of Early Breast Cancer in this Era? Dr. Mayada Fawzy Sedik Farghaly 2020
79 Pegylated liposomal doxorubicin in patients with metastatic triple-negative breast cancer: 8-year experience of a single center Dr. Abeer Elsayed Ali Ibrahim 2020
80 2. The reliability of the computed
tomography perfusion parameters as a
predictor of colorectal cancer grade:
influence of tumor region of interest
position
Dr. Hanaan Ahmed Mohammed Ahmed 2020